Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)
CNY 9.37
(-0.85%)
CNY 9.37
(-0.85%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.14 Billion CNY | 55.47% |
| 2022 | 738.58 Million CNY | 42.7% |
| 2021 | 517.59 Million CNY | -3.53% |
| 2020 | 536.53 Million CNY | 26.28% |
| 2019 | 424.88 Million CNY | -1.02% |
| 2018 | 429.24 Million CNY | 49.73% |
| 2017 | 286.67 Million CNY | -4.13% |
| 2016 | 299.01 Million CNY | 42.27% |
| 2015 | 210.16 Million CNY | 6.57% |
| 2014 | 197.2 Million CNY | 19.03% |
| 2013 | 165.67 Million CNY | -14.79% |
| 2012 | 194.44 Million CNY | 30.1% |
| 2011 | 149.45 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 1.07 Billion CNY | 8.54% |
| 2024 Q1 | 960.12 Million CNY | -16.39% |
| 2024 Q2 | 992.88 Million CNY | 3.41% |
| 2023 FY | 1.14 Billion CNY | 55.47% |
| 2023 Q2 | 1 Billion CNY | 28.39% |
| 2023 Q3 | 1.06 Billion CNY | 5.98% |
| 2023 Q4 | 1.14 Billion CNY | 7.32% |
| 2023 Q1 | 786.34 Million CNY | 6.47% |
| 2022 Q1 | 492.99 Million CNY | -4.75% |
| 2022 Q2 | 648.48 Million CNY | 31.54% |
| 2022 Q4 | 738.58 Million CNY | -3.23% |
| 2022 Q3 | 763.22 Million CNY | 17.69% |
| 2022 FY | 738.58 Million CNY | 42.7% |
| 2021 FY | 517.59 Million CNY | -3.53% |
| 2021 Q1 | 507.29 Million CNY | -5.45% |
| 2021 Q2 | 490.93 Million CNY | -3.22% |
| 2021 Q3 | 504.35 Million CNY | 2.73% |
| 2021 Q4 | 517.59 Million CNY | 2.62% |
| 2020 Q1 | 427.72 Million CNY | 0.67% |
| 2020 FY | 536.53 Million CNY | 26.28% |
| 2020 Q2 | 447.68 Million CNY | 4.67% |
| 2020 Q4 | 536.53 Million CNY | 9.07% |
| 2020 Q3 | 491.94 Million CNY | 9.89% |
| 2019 Q2 | 411.7 Million CNY | -1.72% |
| 2019 Q1 | 418.9 Million CNY | -2.41% |
| 2019 FY | 424.88 Million CNY | -1.02% |
| 2019 Q4 | 424.88 Million CNY | 6.35% |
| 2019 Q3 | 399.52 Million CNY | -2.96% |
| 2018 Q1 | 278.22 Million CNY | -2.95% |
| 2018 FY | 429.24 Million CNY | 49.73% |
| 2018 Q4 | 429.24 Million CNY | 47.46% |
| 2018 Q3 | 291.09 Million CNY | 3.93% |
| 2018 Q2 | 280.07 Million CNY | 0.67% |
| 2017 FY | 286.67 Million CNY | -4.13% |
| 2017 Q1 | 271.26 Million CNY | -9.28% |
| 2017 Q2 | 261.6 Million CNY | -3.56% |
| 2017 Q3 | 272.29 Million CNY | 4.09% |
| 2017 Q4 | 286.67 Million CNY | 5.28% |
| 2016 Q3 | 274.37 Million CNY | 29.21% |
| 2016 Q1 | 203.38 Million CNY | -3.23% |
| 2016 Q2 | 212.34 Million CNY | 4.41% |
| 2016 Q4 | 299.01 Million CNY | 8.98% |
| 2016 FY | 299.01 Million CNY | 42.27% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 210.16 Million CNY | 6.57% |
| 2015 Q3 | 223.31 Million CNY | 0.0% |
| 2015 Q4 | 210.16 Million CNY | -5.89% |
| 2014 Q4 | 197.2 Million CNY | 0.0% |
| 2014 FY | 197.2 Million CNY | 19.03% |
| 2013 FY | 165.67 Million CNY | -14.79% |
| 2012 FY | 194.44 Million CNY | 30.1% |
| 2011 FY | 149.45 Million CNY | 0.0% |